Literature DB >> 16979413

Relationship between polymorphisms 804C/A and 252A/G of lymphotoxin-alpha gene and -308G/A of tumor necrosis factor alpha gene and diabetic retinopathy in Japanese patients with type 2 diabetes mellitus.

Keiji Yoshioka1, Toshihide Yoshida, Yasuto Takakura, Tsunekazu Umekawa, Akinori Kogure, Hitoshi Toda, Toshikazu Yoshikawa.   

Abstract

To clarify whether polymorphisms of the lymphotoxin-alpha (LTA) gene and tumor necrosis factor alpha (TNF-alpha) gene were related to diabetic retinopathy (DR), we performed a case-control study in 251 Japanese patients with type 2 diabetes mellitus participating in a multicenter research protocol. Genetic analyses were performed by using a fluorescent allele-specific DNA primer assay system. Diabetic retinopathy was diagnosed in a masked manner by an independent ophthalmologist using fundus photographs and was classified as nondiabetic retinopathy (NDR), nonproliferative retinopathy (NPDR), and proliferative retinopathy (PDR). The results showed that the genotype frequencies of 804C/A in exon 3 and 252A/G in intron 1 of the LTA gene were not significantly different among patients with NDR, NPDR, and PDR. A allelic frequency of the TNF-alpha gene (-302A/G in promoter) was also identical among NDR, NPDR, and PDR groups. Multivariate logistic regression analyses showed that significant associations with DR were glycosylated hemoglobin level and diabetes duration, but not polymorphisms of the LTA gene or TNF-alpha gene. In conclusion, the present study showed no association between polymorphisms 804C/A and 252A/G of the LTA gene and -302A/G of the TNF-alpha gene and DR in Japanese type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979413     DOI: 10.1016/j.metabol.2006.06.012

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Association of tumor necrosis factor alpha gene polymorphism G-308A with pseudoexfoliative glaucoma in the Pakistani population.

Authors:  Muhammad Imran Khan; Shazia Micheal; Noreen Rana; Farah Akhtar; Anneke I den Hollander; Asifa Ahmed; Raheel Qamar
Journal:  Mol Vis       Date:  2009-12-22       Impact factor: 2.367

Review 2.  Association between diabetic retinopathy and polymorphisms of cytokine genes: a systematic review and meta-analysis.

Authors:  Faria Jafarzadeh; Amin Javanbakht; Niloofar Bakhtar; Alaleh Dalvand; Mahya Shabani; Mohammad-Mehdi Mehrabinejad
Journal:  Int Ophthalmol       Date:  2021-08-25       Impact factor: 2.031

3.  TNF-α (-308) Gene Polymorphism and Type 2 Diabetes Mellitus in Ethiopian Diabetes Patients.

Authors:  Birhanu Ayelign; Meaza Genetu; Tadelo Wondmagegn; Gashaw Adane; Markos Negash; Nega Berhane
Journal:  Diabetes Metab Syndr Obes       Date:  2019-11-28       Impact factor: 3.168

4.  Association of Tumor Necrosis Factor-Alpha-308 G/A and -238 G/A Polymorphism with Diabetic Retinopathy: A Systematic Review and Updated Meta-Analysis.

Authors:  Wenna Gao; Ruilin Zhu; Liu Yang
Journal:  Ophthalmic Res       Date:  2020-12-04       Impact factor: 2.892

5.  EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.

Authors:  Haitao Li; Janice W C Louey; Kwong Wai Choy; David T L Liu; Wai Man Chan; Yiu Man Chan; Nicholas S K Fung; Bao Jian Fan; Larry Baum; Juliana C N Chan; Dennis S C Lam; Chi Pui Pang
Journal:  Mol Vis       Date:  2008-09-15       Impact factor: 2.367

6.  Association of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes Patients.

Authors:  K F Rodrigues; N T Pietrani; V C Sandrim; C M A F Vieira; A P Fernandes; A A Bosco; K B Gomes
Journal:  J Diabetes Res       Date:  2015-05-06       Impact factor: 4.011

7.  In silico analysis of single nucleotide polymorphism (SNP) in human TNF-α gene.

Authors:  Brijesh Dabhi; Kinnari N Mistry
Journal:  Meta Gene       Date:  2014-08-24

Review 8.  Candidate genes for proliferative diabetic retinopathy.

Authors:  Daniel Petrovič
Journal:  Biomed Res Int       Date:  2013-08-27       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.